BILLERICA, Mass.--(BUSINESS WIRE)--After the Company’s Special Stockholders Meeting held this morning in Boston, Bruker BioSciences Corporation (NASDAQ: BRKR) announces that its stockholders have approved the acquisition of the companies comprising the Bruker BioSpin Group.
